GENE ONLINE|News &
Opinion
Blog

Cosentyx
Novartis’ IL-17 Inhibitor Shines in Late-Stage Psoriatic Arthritis Trial
2020-11-06
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
Novartis’ Axial Spondyloarthritis Drug, Cosentyx Shines in Phase 3 Study
2020-06-08
LATEST
Biotech Sector Updates: Reports Cover Research Advances and Industry Events
2025-05-14
GSK Adds Efimosfermin to Hepatology Portfolio, Citing Novel Mechanism of Action for Liver Disease Treatment
2025-05-14
New Generic Drug Impacts Oncology and Community Pharmacists.
2025-05-14
Novo Nordisk and Septerna Partner to Develop Oral Obesity Medications
2025-05-14
Ixchiq Vaccine Adverse Event Investigations Focus on Elderly Recipients
2025-05-14
Liver Disease Treatment Investment Resurges Amid Growing Unmet Needs
2025-05-14
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top